SPI Infoamtion

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What is This Report About?

3 In Vitro Diagnostics In Australia
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, Australia, Overall Revenue ($m), 2002-2016
3.3 In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2009
3.4 In Vitro Diagnostics Market, Australia, Category Contribution (%), 2009
3.5 In Vitro Diagnostics, Australia, Company Share (2008-2009)

4 Clinical Chemistry In Australia
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, Australia, Revenue Mix ($m), 2009
4.3 Clinical Chemistry Market, Australia, Category Contribution (%), 2009
4.4 Clinical Chemistry Overall Revenue (2002-2016)
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016)
4.4.2 Urine Analysis Revenue (2002-2016)
4.5 Clinical Chemistry Distribution Share (2008-2009)
4.6 Clinical Chemistry, Australia, Company Share (2008-2009)

5 Genetic Testing In Australia
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, Australia, Revenue Mix ($m), 2009
5.3 Genetic Testing Market, Australia, Category Contribution (%), 2009
5.4 Genetic Testing Overall Revenue (2002-2016)
5.5 Genetic Testing Distribution Share (2008-2009)
5.6 Genetic Testing, Australia, Company Share (2008-2009)

6 Haematology In Australia
6.1 Haematology, Market Segmentation
6.2 Haematology Market, Australia, Revenue Mix ($m), 2009
6.3 Haematology Market, Australia, Category Contribution (%), 2009
6.4 Haematology Overall Revenue (2002-2016)
6.4.1 Haematology Reagents Revenue (2002-2016)
6.4.2 Immunohaematology Revenue (2002-2016)
6.4.3 Haemostasis Revenue (2002-2016)
6.4.4 Haematology Rapid Tests Revenue (2002-2016)
6.4.5 Haematology Cell Counters Revenue (2002-2016)
6.5 Haematology Distribution Share (2008-2009)
6.6 Haematology, Australia, Company Share (2008-2009)

7 Histology And Cytology In Australia
7.1 Histology and Cytology, Market Segmentation
7.2 Histology and Cytology Market, Australia, Revenue Mix ($m), 2009
7.3 Histology and Cytology Market, Australia, Category Contribution (%), 2009
7.4 Histology and Cytology Overall Revenue (2002-2016)
7.4.1 Histology Revenue (2002-2016)
7.5 Histology and Cytology Distribution Share (2008-2009)
7.6 Histology and Cytology, Australia, Company Share (2008-2009)

8 Immuno Chemistry In Australia
8.1 Immuno Chemistry, Market Segmentation
8.2 Immuno Chemistry Market, Australia, Revenue Mix ($m), 2009
8.3 Immuno Chemistry Market, Australia, Category Contribution (%), 2009
8.4 Immuno Chemistry Overall Revenue (2002-2016)
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016)
8.4.2 Drug Related Testing Revenue (2002-2016)
8.4.3 Endocrinology Tests Revenue (2002-2016)
8.4.4 Immunochemistry Analyzers Revenue (2002-2016)
8.5 Immuno Chemistry Distribution Share (2008-2009)
8.6 Immuno Chemistry, Australia, Company Share (2008-2009)

9 Infectious Immunology In Australia
9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, Australia, Revenue Mix ($m), 2009
9.3 Infectious Immunology Market, Australia, Category Contribution (%), 2009
9.4 Infectious Immunology Overall Revenue (2002-2016)
9.5 Infectious Immunology Distribution Share (2008-2009)
9.6 Infectious Immunology, Australia, Company Share (2008-2009)

10 Microbiology Culture In Australia
10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, Australia, Revenue Mix ($m), 2009
10.3 Microbiology Culture Market, Australia, Category Contribution (%), 2009
10.4 Microbiology Culture Overall Revenue (2002-2016)
10.4.1 Microbiology Analyzers Revenue (2002-2016)
10.5 Microbiology Culture Distribution Share (2008-2009)
10.6 Microbiology Culture, Australia, Company Share (2008-2009)

11 Overview of Key Companies in Australia In Vitro Diagnostics Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 Share in the Australia In Vitro Diagnostics Market
11.2 Siemens Healthcare
11.2.1 Company Overview
11.2.2 Share in the Australia In Vitro Diagnostics Market
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Share in the Australia In Vitro Diagnostics Market
11.4 Beckman Coulter, Inc.
11.4.1 Company Overview
11.4.2 Share in the Australia In Vitro Diagnostics Market
11.5 Sysmex Corporation
11.5.1 Company Overview
11.5.2 Share in the Australia In Vitro Diagnostics Market
11.6 bioMerieux S.A.
11.6.1 Company Overview
11.6.2 Share in the Australia In Vitro Diagnostics Market
11.7 Dade Behring Holdings, Inc.
11.7.1 Company Overview
11.8 OLYMPUS CORPORATION
11.8.1 Company Overview
11.9 Inverness Medical Innovations, Inc.
11.9.1 Company Overview
11.10 Becton, Dickinson and Company
11.10.1 Company Overview
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Company Overview
11.12 Hologic, Inc.
11.12.1 Company Overview
11.13 Digene Corporation
11.13.1 Company Overview
11.14 Ventana Medical Systems, Inc.
11.14.1 Company Overview
11.15 Ortho-Clinical Diagnostics Inc.
11.15.1 Company Overview
11.16 DiaSorin S.p.A
11.16.1 Company Overview
11.17 Qiagen N.V.
11.17.1 Company Overview
11.18 Gen-Probe Incorporated
11.18.1 Company Overview
11.19 Phadia AB
11.19.1 Company Overview
11.20 Black Ridge Mining Limited
11.20.1 Company Overview
11.21 Roche Diagnostics Australia Pty. Ltd.
11.21.1 Company Overview
11.22 Diagnostic Technology Pty Ltd
11.22.1 Company Overview
11.23 Anteo Diagnostics Limited
11.23.1 Company Overview
11.24 Cellestis Limited
11.24.1 Company Overview
11.25 NuSep Ltd
11.25.1 Company Overview
11.26 Vision BioSystems Ltd
11.26.1 Company Overview
11.27 Holista CollTech Limited
11.27.1 Company Overview
11.28 Tyrian Diagnostics Limited
11.28.1 Company Overview
11.29 LabTech Systems Limited
11.29.1 Company Overview
11.30 Rockeby Biomed Limited
11.30.1 Company Overview
11.31 Universal Biosensors, Inc.
11.31.1 Company Overview
11.32 GeneWorks Pty. Ltd.
11.32.1 Company Overview
11.33 Astral Scientific Pty Ltd
11.33.1 Company Overview
11.34 Banksia Scientific Pte Ltd
11.34.1 Company Overview
11.35 Enterix Australia Pty Ltd
11.35.1 Company Overview
11.36 HealthLinx Limited
11.36.1 Company Overview
11.37 Panbio Limited
11.37.1 Company Overview
11.38 Genera Biosystems Limited
11.38.1 Company Overview
11.39 Quintain NanoSystems
11.40 Mosaic Medical (Asia Pacific) Pty Ltd
11.40.1 Company Overview
11.41 Australasian Medical & Scientific Limited
11.41.1 Company Overview
11.42 TGR BioSciences Pty Ltd
11.42.1 Company Overview

12 In Vitro Diagnostics Market Pipeline Products
12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology and Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products

13 Financial Deals Landscape
13.1 Partnerships
13.1.1 QIAGEN Enters Into Distribution Agreement With Celera
13.1.2 Sequenom Enters Into Licensing Agreement With Optherion
13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
13.1.4 Rubicon Genomics Enters Into Agreement With ZyGEM
13.1.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics
13.1.6 Anteo Diagnostics Enters Into Licensing Agreement With Bangs Laboratories
13.1.7 Response Genetics Enters Into Distribution Agreement With Genetic Technologies
13.1.8 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
13.1.9 Celera Enters Into Licensing Agreement With Medical Therapies
13.1.10 Rosetta Genomics Enters Into An Agreement With Genetic Technologies
13.2 Recent Developments
13.3 Government and Public Interest
13.3.1 Apr 27, 2010: New Diagnostic Kit To Improve Health Outcomes For HIV Patients
13.3.2 Aug 19, 2009: Quick And Accurate Way Of Diagnosing Endometriosis
13.4 Product News
13.4.1 Apr 05, 2010: PinPointe Launches PinPointe FootLaser Treatment In Australia
13.4.2 Jan 22, 2010: Genera Biosystems Announces TGA Approval For PapType HPV Detection And Genotyping Test

14 Appendix
14.1 Definitions of Markets Covered in the Report
14.1.1 In Vitro Diagnostics
14.2 Research Methodology
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Forecasts
14.7 Expert Panels
14.8 GlobalData Consulting
14.9 Currency Conversion
14.10 Contact Us
14.11 Disclaimer

List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation
Figure 2: In Vitro Diagnostics, Australia, Overall Revenue ($m), 2002-2016
Figure 3: In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2009
Figure 4: In Vitro Diagnostics Market, Australia, Category Contribution (%), 2009
Figure 5: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2002-2016
Figure 6: In Vitro Diagnostics, Australia, Overall Revenue ($m), Historic, 2002-2009
Figure 7: In Vitro Diagnostics, Australia, Overall Revenue ($m), Forecast, 2009-2016
Figure 8: In Vitro Diagnostics, Australia, Company Share (%), 2009
Figure 9: Clinical Chemistry, Market Segmentation
Figure 10: Clinical Chemistry Market, Australia, Revenue Mix ($m), 2009
Figure 11: Clinical Chemistry Market, Australia, Category Contribution (%), 2009
Figure 12: Clinical Chemistry, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Figure 13: Clinical Chemistry, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 14: Clinical Chemisty Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 15: Clinical Chemisty Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 16: Urine Analysis, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 17: Urine Analysis, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 18: Clinical Chemistry, Australia, Company Share (%), 2009
Figure 19: Genetic Testing, Market Segmentation
Figure 20: Genetic Testing Market, Australia, Revenue Mix ($m), 2009
Figure 21: Genetic Testing Market, Australia, Category Contribution (%), 2009
Figure 22: Genetic Testing, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Figure 23: Genetic Testing, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 24: Genetic Testing, Australia, Company Share (%), 2009
Figure 25: Haematology, Market Segmentation
Figure 26: Haematology Market, Australia, Revenue Mix ($m), 2009
Figure 27: Haematology Market, Australia, Category Contribution (%), 2009
Figure 28: Haematology, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Figure 29: Haematology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 30: Haematology Reagents, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 31: Haematology Reagents, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 32: Immunohaematology, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 33: Immunohaematology, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 34: Haemostasis, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 35: Haemostasis, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 36: Haematology Rapid Tests, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 37: Haematology Rapid Tests, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 38: Haematology Cell Counters, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 39: Haematology Cell Counters, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 40: Haematology, Australia, Company Share (%), 2009
Figure 41: Histology and Cytology, Market Segmentation
Figure 42: Histology and Cytology Market, Australia, Revenue Mix ($m), 2009
Figure 43: Histology and Cytology Market, Australia, Category Contribution (%), 2009
Figure 44: Histology And Cytology, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Figure 45: Histology And Cytology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 46: Histology, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 47: Histology, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 48: Histology And Cytology, Australia, Company Share (%), 2009
Figure 49: Immuno Chemistry, Market Segmentation
Figure 50: Immuno Chemistry Market, Australia, Revenue Mix ($m), 2009
Figure 51: Immuno Chemistry Market, Australia, Category Contribution (%), 2009
Figure 52: Immuno Chemistry, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Figure 53: Immuno Chemistry, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 54: Disease Specific Immunochemistry, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 55: Disease Specific Immunochemistry, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 56: Drug Related Testing, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 57: Drug Related Testing, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 58: Endocrinology Tests, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 59: Endocrinology Tests, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 60: Immunochemistry Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 61: Immunochemistry Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 62: Immuno Chemistry, Australia, Company Share (%), 2009
Figure 63: Infectious Immunology, Market Segmentation
Figure 64: Infectious Immunology Market, Australia, Revenue Mix ($m), 2009
Figure 65: Infectious Immunology Market, Australia, Category Contribution (%), 2009
Figure 66: Infectious Immunology, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Figure 67: Infectious Immunology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 68: Infectious Immunology, Australia, Company Share (%), 2009
Figure 69: Microbiology Culture, Market Segmentation
Figure 70: Microbiology Culture Market, Australia, Revenue Mix ($m), 2009
Figure 71: Microbiology Culture Market, Australia, Category Contribution (%), 2009
Figure 72: Microbiology Culture, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Figure 73: Microbiology Culture, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 74: Microbiology Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 75: Microbiology Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 76: Microbiology Culture, Australia, Company Share (%), 2009
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%), Australia In Vitro Diagnostics Market, 2009
Figure 78: Siemens Healthcare, Company Share (%), Australia In Vitro Diagnostics Market, 2009
Figure 79: Abbott Laboratories, Company Share (%), Australia In Vitro Diagnostics Market, 2009
Figure 80: Beckman Coulter, Inc., Company Share (%), Australia In Vitro Diagnostics Market, 2009
Figure 81: Sysmex Corporation, Company Share (%), Australia In Vitro Diagnostics Market, 2009
Figure 82: bioMerieux S.A., Company Share (%), Australia In Vitro Diagnostics Market, 2009
Figure 83: GlobalData Methodology

List of Tables
Table 1: In Vitro Diagnostics, Australia, Overall Revenue ($m), 2002-2016
Table 2: In Vitro Diagnostics Market, Australia, Category Contribution (%), 2009
Table 3: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2002-2016
Table 4: In Vitro Diagnostics, Australia, Overall Revenue ($m), Historic, 2002-2009
Table 5: In Vitro Diagnostics, Australia, Overall Revenue ($m), Forecast, 2009-2016
Table 6: In Vitro Diagnostics, Australia, Company Share by Revenue ($m), 2008-2009
Table 7: Clinical Chemistry Market, Australia, Category Contribution (%), 2009
Table 8: Clinical Chemistry, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Table 9: Clinical Chemistry, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Table 10: Clinical Chemisty Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 11: Clinical Chemisty Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 12: Urine Analysis, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 13: Urine Analysis, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 14: Clinical Chemistry, Australia, Distribution Share by Revenue ($m), 2008-2009
Table 15: Clinical Chemistry, Australia, Company Share by Revenue ($m), 2008-2009
Table 16: Genetic Testing Market, Australia, Category Contribution (%), 2009
Table 17: Genetic Testing, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Table 18: Genetic Testing, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Table 19: Genetic Testing, Australia, Distribution Share by Revenue ($m), 2008-2009
Table 20: Genetic Testing, Australia, Company Share by Revenue ($m), 2008-2009
Table 21: Haematology Market, Australia, Category Contribution (%), 2009
Table 22: Haematology, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Table 23: Haematology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Table 24: Haematology Reagents, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 25: Haematology Reagents, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 26: Immunohaematology, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 27: Immunohaematology, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 28: Haemostasis, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 29: Haemostasis, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 30: Haematology Rapid Tests, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 31: Haematology Rapid Tests, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 32: Haematology Cell Counters, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 33: Haematology Cell Counters, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 34: Haematology, Australia, Distribution Share by Revenue ($m), 2008-2009
Table 35: Haematology, Australia, Company Share by Revenue ($m), 2008-2009
Table 36: Histology and Cytology Market, Australia, Category Contribution (%), 2009
Table 37: Histology And Cytology, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Table 38: Histology And Cytology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Table 39: Histology, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 40: Histology, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 41: Histology And Cytology, Australia, Distribution Share by Revenue ($m), 2008-2009
Table 42: Histology And Cytology, Australia, Company Share by Revenue ($m), 2008-2009
Table 43: Immuno Chemistry Market, Australia, Category Contribution (%), 2009
Table 44: Immuno Chemistry, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Table 45: Immuno Chemistry, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Table 46: Disease Specific Immunochemistry, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 47: Disease Specific Immunochemistry, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 48: Drug Related Testing, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 49: Drug Related Testing, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 50: Endocrinology Tests, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 51: Endocrinology Tests, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 52: Immunochemistry Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 53: Immunochemistry Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 54: Immuno Chemistry, Australia, Distribution Share by Revenue ($m), 2008-2009
Table 55: Immuno Chemistry, Australia, Company Share by Revenue ($m), 2008-2009
Table 56: Infectious Immunology Market, Australia, Category Contribution (%), 2009
Table 57: Infectious Immunology, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Table 58: Infectious Immunology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Table 59: Infectious Immunology, Australia, Distribution Share by Revenue ($m), 2008-2009
Table 60: Infectious Immunology, Australia, Company Share by Revenue ($m), 2008-2009
Table 61: Microbiology Culture Market, Australia, Category Contribution (%), 2009
Table 62: Microbiology Culture, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Table 63: Microbiology Culture, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Table 64: Microbiology Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 65: Microbiology Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 66: Microbiology Culture, Australia, Distribution Share by Revenue ($m), 2008-2009
Table 67: Microbiology Culture, Australia, Company Share by Revenue ($m), 2008-2009
Table 68: Clinical Chemisty Market Pipeline Products
Table 69: Immuno Chemistry Market Pipeline Products
Table 70: Haematology Market Pipeline Products
Table 71: Infectious Immunology Market Pipeline Products
Table 72: Microbiology Culture Market Pipeline Products
Table 73: Histology and Cytology Market Pipeline Products
Table 74: Genetic Testing Market Pipeline Products
Table 75: QIAGEN Enters Into Distribution Agreement With Celera
Table 76: Sequenom Enters Into Licensing Agreement With Optherion
Table 77: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
Table 78: Rubicon Genomics Enters Into Agreement With ZyGEM
Table 79: OraSure Technologies Enters Into An Agreement With Roche Diagnostics
Table 80: Anteo Diagnostics Enters Into Licensing Agreement With Bangs Laboratories
Table 81: Response Genetics Enters Into Distribution Agreement With Genetic Technologies
Table 82: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
Table 83: Celera Enters Into Licensing Agreement With Medical Therapies
Table 84: Rosetta Genomics Enters Into An Agreement With Genetic Technologies
Table 85: USD to Local Currency, Australia, Average Actual Rate 2002-2009